Antigen-specific peripheral tolerance induced by topical application of NF-kappaB decoy oligodeoxynucleotide

J Invest Dermatol. 2006 Jan;126(1):97-104. doi: 10.1038/sj.jid.5700027.

Abstract

Activation and maturation of dendritic cells (DC) are crucial for the establishment of delayed-type hypersensitivity (DTH). However, antigen presentation by immature DC (iDC) might lead to antigen-specific peripheral tolerance. NF-kappaB plays significant roles in upregulation of co-stimulatory molecules and cytokines in DC and therefore we investigated whether NF-kappaB decoy oligodeoxynucleotide (ODN) might induce tolerance to DTH. NF-kappaB decoy ODN suppressed ovalbumin (OVA)-induced DTH responses not only in naïve but also in presensitized mice. The suppressive effect was found to be antigen-specific. NF-kappaB decoy ODN-induced tolerance involved CD4(+)CD25(+) regulatory T cells (Treg), because in vivo depletion of CD25(+) T cells abrogated the tolerance, whereas adoptive transfer of such T cell population from tolerant mice induced tolerance. Furthermore, the induction of Treg was related to insufficient migration and/or maturation of DC, because a sizable DC population still remained in peripheral tissue even after exposure to exogenous antigen in NF-kappaB decoy ODN-treated mice. Even if they migrated into lymph nodes, they showed insufficient upregulation of co-stimulatory molecules and impaired antigen-specific activation of T cells. Topical application of NF-kappaB decoy ODN might thus be a new approach to induce antigen-specific peripheral tolerance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4 Antigens / immunology
  • Cell Movement / drug effects
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology
  • Hypersensitivity, Delayed / immunology
  • Hypersensitivity, Delayed / prevention & control*
  • Immune Tolerance
  • Immunosuppression Therapy*
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred BALB C
  • Ointments
  • Oligodeoxyribonucleotides / administration & dosage*
  • Ovalbumin / immunology
  • Receptors, Interleukin-2 / immunology
  • Skin / drug effects
  • T-Lymphocytes, Regulatory / drug effects*
  • T-Lymphocytes, Regulatory / immunology

Substances

  • CD4 Antigens
  • NF-kappaB decoy
  • Ointments
  • Oligodeoxyribonucleotides
  • Receptors, Interleukin-2
  • Ovalbumin